Damora Therapeutics, Inc. (DMRA)
21.49
-0.52
(-2.36%)
USD |
NASDAQ |
Oct 30, 16:00
21.48
0.00 (0.00%)
After-Hours: 20:00
Damora Therapeutics EPS Diluted (Quarterly) : -0.5099 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5099 |
| March 31, 2026 | -0.8092 |
| December 31, 2025 | -121.10 |
| September 30, 2025 | -2.361 |
| June 30, 2025 | -2.599 |
| March 31, 2025 | -1.916 |
| December 31, 2024 | -5.224 |
| September 30, 2024 | -3.391 |
| June 30, 2024 | -4.922 |
| March 31, 2024 | -5.050 |
| December 31, 2023 | -5.970 |
| September 30, 2023 | -7.504 |
| June 30, 2023 | -10.18 |
| Date | Value |
|---|---|
| March 31, 2023 | -12.65 |
| December 31, 2022 | -13.72 |
| September 30, 2022 | -13.46 |
| June 30, 2022 | -16.71 |
| March 31, 2022 | -16.76 |
| December 31, 2021 | -13.27 |
| September 30, 2021 | -12.56 |
| June 30, 2021 | -12.17 |
| March 31, 2021 | -13.21 |
| December 31, 2020 | -3.888 |
| September 30, 2020 | -14.22 |
| March 31, 2020 | -5.615 |
| September 30, 2019 | -5.449 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.17M |
| Total Expenses (Quarterly) | 31.17M |
| Enterprise Value | 916.55M |
| Earnings Yield | -580.7% |
| Normalized Earnings Yield | -238.11 |